Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2023-12-21
2030-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult patients with hematologic disease who will receive double unit cord blood tranplant
tranplant
double unit cord blood transplnat
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tranplant
double unit cord blood transplnat
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute leukemia (myeloid/lymphoid/mixed lineage) planned for transplantation for treatment purposes
* Myelodysplastic syndromes planned for transplantation for treatment purposes ③ Chronic leukemia (myeloid/lymphoid/monocytic) and myeloproliferative neoplasms planned for transplantation for treatment purposes ④ Malignant lymphomas, multiple myeloma planned for transplantation for treatment purposes ⑤ Other malignant hematologic malignancies planned for transplantation for treatment purposes ⑥ Planned for transplantation for the treatment of bone marrow failure diseases, including aplastic anemia (3) If all contents of the consent form are understood and consented to in writing.
Exclusion Criteria
(2) Patients with severe, uncontrolled infections or severe cardiopulmonary dysfunction, as judged by the investigator.
(3) Patients with an ECOG Performance Status (PS) greater than 3 or those receiving mechanical ventilation in the intensive care unit.
(4) Patients who do not consent to participate in the study or those deemed unsuitable for sincere participation by the attending physician.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong-Yeop Shin
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dong-Yeop Shin, MD, PhD.
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Sung-Soo Yoon, MD, PhD.
Role: STUDY_DIRECTOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jeonbuk National University Hopital
Jeonju, Jeonlabuk-do, South Korea
Keimyung Unversity Dongsan Hospital
Daegu, , South Korea
Dong-A University Hospital
Pusan, , South Korea
Pusan National University Hospital
Pusan, , South Korea
Seoul National University Bundang Hospital
Seongnam, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ho Young Yhim
Role: primary
Jae Yong Kwak
Role: backup
Young Rok Do
Role: primary
Sung Hyun Kim
Role: primary
Ji Hyun Lee
Role: backup
Do Young Kim
Role: primary
Ho Jin Shin
Role: backup
Soo Mee Bang
Role: primary
Jeong Ok Lee
Role: backup
Dong-Yeop Shin, MD, PhD
Role: primary
Eunhee Park, RN
Role: backup
Dong-Yeop Shin
Role: backup
Sung-Soo Yoon
Role: backup
Junshik Hong
Role: backup
Ja Min Byun
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRODUCT-K
Identifier Type: -
Identifier Source: org_study_id